Proteins and Peptides

13 Feb 2018 Sandoz announces US FDA approval and launch of Glatopa® 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
13 Feb 2018 Ra Pharmaceuticals Announces Completion of Dosing in Phase 2 Program of RA101495 SC in Paroxysmal Nocturnal Hemoglobinuria
09 Feb 2018 Catalyst Biosciences Announces Positive Top-Line Data from Phase 1/2 Study of Subcutaneous CB 2679d/ISU304 in Individuals with Hemophilia B
09 Feb 2018 Novo Nordisk A/S: Ozempic® (semaglutide) approved in the EU for the treatment of type 2 diabetes
08 Feb 2018 Bonti Announces Dosing of the First Patient in the SHINE-1 Phase 2 Clinical Study Evaluating EB-001 for Scar Reduction
08 Feb 2018 BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at WORLDSymposium™ 2018
08 Feb 2018 Sanofi announces new safety data for investigational avalglucosidase alfa in patients with Pompe disease
07 Feb 2018 Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis
06 Feb 2018 Endo Announces Initiation Of Two Pivotal Phase 3 Clinical Trials Of Collagenase Clostridium Histolyticum For The Treatment Of Cellulite
06 Feb 2018 Spectrum Pharmaceuticals Announces ROLONTIS™ (eflapegrastim) Met the Primary Endpoint in the Phase 3 ADVANCE Study
01 Feb 2018 Ferring's ZOMACTON® (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficiency in Adults
01 Feb 2018 Partner Therapeutics (PTx) Acquires Leukine® from Sanofi
30 Jan 2018 Amgen Receives CHMP Positive Opinion To Add Updated Overall Survival Data To KYPROLIS® (carfilzomib) Label
29 Jan 2018 Mylan and Biocon Receive Positive CHMP Opinion for Semglee™, Biosimilar Insulin Glargine
29 Jan 2018 ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC
27 Jan 2018 Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors
25 Jan 2018 Synergy Pharmaceuticals Announces FDA Approval of TRULANCE® (Plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
25 Jan 2018 Generon Successfully Concludes First Phase III Clinical Trial of F-627 for Chemotherapy-Induced Neutropenia
24 Jan 2018 Biomarck Announces the Start of a Phase 2 Clinical Trial of BIO-11006 for Non-Small Cell Lung Cancer (NSCLC)
23 Jan 2018 FDA accepts investigational new drug application and grants Fast Track status for SOBI003 for the treatment of MPS IIIA
23 Jan 2018 New clinical evidence support potential for glepaglutide as a once-weekly drug for short bowel syndrome (SBS)
22 Jan 2018 Baxter Announces U.S. FDA Approval of Ready-to-Use Cardiovascular Medication Bivalirudin
22 Jan 2018 Octapharma: Low inhibitor rate with octanate® in previously untreated patients (PUPs) with severe haemophilia A
20 Jan 2018 Zealand Pharma announces progress to Phase 3 with dasiglucagon for the treatment of congenital hyperinsulinism in first half 2018
18 Jan 2018 FDA Approves Addition Of Overall Survival Data To KYPROLIS® (carfilzomib) Label

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up